The July meeting is a beginning, not an end
In the 2024 WADA Prohibited List (World Anti-Doping Agency, 2024c) Section 4: hormone and metabolic modulators, AIs (Subsection S4.1) and anti-estrogenic substances, including anti-estrogens and SERMs (Subsection S4.2), are prohibited at all times (in- and out-of-competition)
74% of Medicare Advantage plans and Medicare Part D plans cover Repatha
There are documented cases of contamination, infection, and adverse reactions from grey-market peptides
Healthcare providers assess symptoms and medical history to determine the need for further testing
It's important to note that individual results may vary, and patients should have realistic expectations